JP2003012555A5 - - Google Patents

Download PDF

Info

Publication number
JP2003012555A5
JP2003012555A5 JP2001197612A JP2001197612A JP2003012555A5 JP 2003012555 A5 JP2003012555 A5 JP 2003012555A5 JP 2001197612 A JP2001197612 A JP 2001197612A JP 2001197612 A JP2001197612 A JP 2001197612A JP 2003012555 A5 JP2003012555 A5 JP 2003012555A5
Authority
JP
Japan
Prior art keywords
behavior
animal
gaba
receptor agonist
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2001197612A
Other languages
Japanese (ja)
Other versions
JP4438256B2 (en
JP2003012555A (en
Filing date
Publication date
Application filed filed Critical
Priority claimed from JP2001197612A external-priority patent/JP4438256B2/en
Priority to JP2001197612A priority Critical patent/JP4438256B2/en
Priority to US10/176,609 priority patent/US6939894B2/en
Priority to DE60201219T priority patent/DE60201219T2/en
Priority to EP02013992A priority patent/EP1270002B1/en
Priority to AT02013992T priority patent/ATE275972T1/en
Priority to CA002390189A priority patent/CA2390189C/en
Publication of JP2003012555A publication Critical patent/JP2003012555A/en
Publication of JP2003012555A5 publication Critical patent/JP2003012555A5/ja
Publication of JP4438256B2 publication Critical patent/JP4438256B2/en
Application granted granted Critical
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Description

【特許請求の範囲】
【請求項１】
GABAB受容体アゴニストおよびGABAA受容体アゴニストからなる群より選ばれる物質、また
はこれらの組み合わせを動物に投与することを含む、動物の問題行動を防止する方法。
【請求項２】
問題行動が、常同行動または分離不安に起因する行動または強迫神経症に起因する行動の
いずれかであることを特徴とする、請求項１に記載の方法。
【請求項３】
問題行動が無駄吠えであることを特徴とする、請求項１〜２のいずれか１項に記載の方法
。
【請求項４】
動物がイヌであることを特徴とする、請求項１〜３のいずれか1項に記載の方法。
【請求項５】
GABAA受容体アゴニストがGABA、イソグバシン、ムシモールおよびTHIPからなる群より選
ばれることを特徴とする、請求項１〜４のいずれか1項に記載の方法。
【請求項６】
GABAB受容体アゴニストがGABA、バクロフェンおよびSKF97541からなる群より選ばれるこ
とを特徴とする、請求項１〜４のいずれか1項に記載の方法。
【請求項７】
GABAを動物に投与することを含む、動物の問題行動を防止する方法。
【請求項８】
問題行動が、常同行動または分離不安に起因する行動または強迫神経症に起因する行動の
いずれかであることを特徴とする、請求項７に記載の方法。
【請求項９】
問題行動が無駄吠えであることを特徴とする、請求項７〜８のいずれか１項に記載の方法
。
【請求項１０】
動物が伴侶動物であることを特徴とする、請求項７〜９のいずれか1項に記載の方法。
【請求項１１】
動物がイヌであることを特徴とする、請求項７〜１０のいずれか1項に記載の方法。 [Claims]
[Claim 1]
A method for preventing problem behavior of an animal, comprising administering to the animal a substance selected from the group consisting of a GABA B receptor agonist and a GABA A receptor agonist, or a combination thereof.
[Claim 2]
The method according to claim 1 , wherein the problem behavior is either a behavior caused by stereotypic behavior, separation anxiety, or behavior caused by obsessive-compulsive disorder.
[Claim 3]
Wherein the problem behavior is bark waste, the method according to any one of claims 1-2.
[Claim 4]
The method according to claim 1, wherein the animal is a dog.
[Claim 5]
The method according to any one of claims 1 to 4 , wherein the GABA A receptor agonist is selected from the group consisting of GABA, isogubacin, muscimol and THIP.
[Claim 6]
The method according to any one of claims 1 to 4 , characterized in that the GABA B receptor agonist is selected from the group consisting of GABA, baclofen and SKF97541.
[Claim 7]
A method of preventing an animal's problem behavior, comprising administering GABA to the animal.
[Claim 8]
If the problem behavior is behavior caused by stereotypic behavior, separation anxiety or behavior due to obsessive-compulsive disorder
The method according to claim 7, wherein the method is any one.
[Claim 9]
9. A method according to any one of claims 7 to 8, characterized in that the problem behavior is useless.
.
10. Claim
The method according to claim 7, wherein the animal is a companion animal.
11. Claims
The method according to any one of claims 7 to 10, characterized in that the animal is a dog.

JP2001197612A 2001-06-29 2001-06-29 Pharmaceutical composition and method for preventing problem behavior in moving animals Expired - Lifetime JP4438256B2 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
JP2001197612A JP4438256B2 (en) 2001-06-29 2001-06-29 Pharmaceutical composition and method for preventing problem behavior in moving animals
US10/176,609 US6939894B2 (en) 2001-06-29 2002-06-24 Methods for reducing excessive barking of a dog
AT02013992T ATE275972T1 (en) 2001-06-29 2002-06-26 PHARMACEUTICAL COMPOSITIONS FOR PREVENTING PROBLEMATIC BEHAVIOR IN PETS
EP02013992A EP1270002B1 (en) 2001-06-29 2002-06-26 Pharmaceutical compositions for preventing problem behaviour of companion animals
DE60201219T DE60201219T2 (en) 2001-06-29 2002-06-26 Pharmaceutical compositions for preventing problematic behavior in pets
CA002390189A CA2390189C (en) 2001-06-29 2002-06-28 Methods and pharmaceutical compositions for preventing problem behaviors of companion animals

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2001197612A JP4438256B2 (en) 2001-06-29 2001-06-29 Pharmaceutical composition and method for preventing problem behavior in moving animals

Publications (3)

Publication Number Publication Date
JP2003012555A JP2003012555A (en) 2003-01-15
JP2003012555A5 true JP2003012555A5 (en) 2009-09-03
JP4438256B2 JP4438256B2 (en) 2010-03-24

Family

ID=19035181

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001197612A Expired - Lifetime JP4438256B2 (en) 2001-06-29 2001-06-29 Pharmaceutical composition and method for preventing problem behavior in moving animals

Country Status (6)

Country Link
US (1) US6939894B2 (en)
EP (1) EP1270002B1 (en)
JP (1) JP4438256B2 (en)
AT (1) ATE275972T1 (en)
CA (1) CA2390189C (en)
DE (1) DE60201219T2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1452096A4 (en) * 2001-11-29 2004-12-22 Ajinomoto Kk Method of fattening poultry
JP2005132747A (en) * 2003-10-29 2005-05-26 Ajinomoto Co Inc Aged pet ageing behavior-improving agent
US8915216B2 (en) 2006-04-28 2014-12-23 Thomas Barry Hoegh Kennel with automatically opening door
US8127718B2 (en) * 2006-04-28 2012-03-06 Thomas Barry Hoegh Kennel with automatically opening door
JP7065871B2 (en) * 2016-12-13 2022-05-12 オリオン コーポレーション Dexmedetomidine or medetomidine for use in the treatment of canine separation anxiety

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4975430A (en) * 1989-06-16 1990-12-04 The State Of Oregon Acting By And Through The State Board Of Education On Behalf Of The Oregon Health Sciences University CNQX and its analogs as therapeutics for degenerative neural diseases
US5554383A (en) * 1995-04-06 1996-09-10 Trustees Of Tufts College Veterinary method for clinically modifying the behavior of dogs exhibiting canine affective aggression
WO1999045906A1 (en) 1998-03-09 1999-09-16 Trustees Of Tufts College Treatment of compulsive behaviours in man and animals
US6380176B2 (en) 2000-03-28 2002-04-30 Ajinomoto Co., Inc. Method for inhibiting non-intentional behavior with a running neuron inhibitory substance

Similar Documents

Publication Publication Date Title
Mikkelsen Specifying who: On the structure, meaning, and use of specificational copular clauses
ITTO20000963A0 (en) PROLONGED RELEASE MICROPARTICLE AND METHOD FOR ITS PREPARATION.
CL2004000643A1 (en) PHARMACEUTICAL COMPOSITION INCLUDING A 5-HT 1B / 1D AGONIST AND A SELECTIVE CYCLLOXYGENASA-2 INHIBITOR, USEFUL IN THE TREATMENT OF MIGRANE.
WO2005053422A3 (en) Method to reduce odor of excreta from companion animals
EP1599811A4 (en) System and method for semantic knowledge retrieval, management, capture, sharing, discovery, delivery and presentation
GB2372354A (en) Digital rights management
MA27265A1 (en) OPIOID AGONIST FORMULATIONS WITH RELEASEABLE AND SEQUESTRED ANTAGONIST
ATE557006T1 (en) 4-HYDROXYBENZOMORPHANES
WO2005019985A3 (en) System for incorporating information about a source and usage of a media asset into the asset itself
WO2001065508A3 (en) Interactive wagering system with criteria wagering
DE50114129D1 (en) ENDOPARASITICIDES FOR THE VOLUNTARY ORAL INCLUSION BY ANIMALS
JP2003012555A5 (en)
FR2804999B1 (en) DEVICE FOR LIMITING THE REGIME OF A TURBOCHARGER
Morales-Montor et al. Helminth infection alters mood and short-term memory as well as levels of neurotransmitters and cytokines in the mouse hippocampus
CY1108502T1 (en) CONTROLLED-RELEASE COMPOSITIONS CONTAINING ANY OPTIONAL AND COMPETITOR
TRAINING VOLT
ATE358470T1 (en) CONTROLLED RELEASE PHARMACEUTICAL COMPOSITION AND METHOD FOR THE PRODUCTION THEREOF
ATE465715T1 (en) ORAL DELIVERY SYSTEM WITH A BILIQUID FOAM
EE04765B1 (en) Horse harness, urine collection device and head
Thamsborg et al. Influence of different forages on gastrointestinal namatode infections in grazing lambs
Vierboom et al. Pain relief in nonhuman primate models of arthritis
JP2003522230A5 (en)
DE60130676D1 (en) CYCLOHEXYL (ALKYL) PROPANOLAMINES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEREOF
Waters It is time to take animal cruelty out of the'too difficult'box?
FR2865893B1 (en) SMOKING DEVICE FOR SMOKING BEES